lexaria glp 1 What Did We Learn From Lexaria' GLP-1 Study? Lexaria Bioscience CEO Rich Christopher

Numerous signaling pathways, such as cyclooxygenase 2 (COX-2), mammalian target of rapamycin (mTOR), mitogen-activated protein kinase (MAPK) signaling, phosphoinositide 3 kinase (PI3K), and the GATA4/p62-mediated autophagy pathways result in the stimulation of NF-B and/or C/EBP pathways, which in turn regulate the SASP secretome (81, 82)

The GLP-1 component provides appetite suppression and glycemic control

The advantage of compounded tirzepatide over brand-name for microdosing is flexibility

Clinical value of plasma pTau181 to predict Alzheimers disease pathology in a large real-world cohort of a memory clinic

Joe Rogan and Semaglutide In a recent podcast episode, Rogan discussed the growing popularity of semaglutide, a medication used for weight loss